TEOJX
Price
$12.91
Change
+$0.14 (+1.10%)
Updated
Jul 31 closing price
Net Assets
356.92M
VEMAX
Price
$48.64
Change
+$0.61 (+1.27%)
Updated
Jul 31 closing price
Net Assets
163.32B
Interact to see
Advertisement

TEOJX vs VEMAX

TEOJX vs VEMAX Comparison Chart in %
View a ticker or compare two or three
VS
TEOJX vs. VEMAX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TEOJX is a Buy and VEMAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEMAX has more cash in the bank: 163B vs. TEOJX (357M). VEMAX pays higher dividends than TEOJX: VEMAX (2.32) vs TEOJX (0.86). TEOJX was incepted earlier than VEMAX: TEOJX (7 years) vs VEMAX (20 years). TEOJX (0.97) is less costly to investors than VEMAX (0.13). TEOJX is a more actively managed with annual turnover of: 35.00 vs. VEMAX (6.00). TEOJX has a lower initial minimum investment than VEMAX: TEOJX (0) vs VEMAX (3000). TEOJX annual gain was more profitable for investors over the last year : 35.05 vs. VEMAX (19.34). VEMAX return over 5 years is better than : 27.49 vs. TEOJX (18.19).
TEOJXVEMAXTEOJX / VEMAX
Total Expense Ratio0.950.13731%
Annual Report Gross Expense Ratio0.970.13746%
Fund Existence7 years20 years-
Gain YTD19.5379.106215%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets357M163B0%
Annual Yield % from dividends0.862.3237%
Returns for 1 year35.0519.34181%
Returns for 3 years69.7646.41150%
Returns for 5 years18.1927.4966%
Returns for 10 yearsN/A89.08-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MDFGX30.490.46
+1.53%
BlackRock Capital Appreciation Inv A
OIEQX28.620.24
+0.85%
JPMorgan Equity Income R4
GTLOX23.840.06
+0.25%
Glenmede Disciplined US Eq Ptf
CSDGX17.130.04
+0.23%
Copeland SMID Cap Dividend Growth A
GTMUX24.78-0.03
-0.12%
Goldman Sachs Small/Mid Cap Growth R6